Patent Assignment
Reel/Frame 059237/0638
Security Interest
Recorded: 2022-03-11
Pages: 22
Assignor
ACER THERAPEUTICS INC.
Executed: 2022-03-04
Assignee
SWK FUNDING LLC
14755 PRESTON ROAD, SUITE 105, DALLAS, TEXAS, 75254
Covered Properties
(26)
Methods of Treating Coronavirus Infections
PCT:
PCT/US2021/024399 ↗
Methods of Administering Taste Masked Phenylbutyrate and Compositions Therefor
PCT:
PCT/US2021/040760 ↗
Nk Receptor Antagonists for Cancer Patients
PCT:
PCT/US2021/044016 ↗
Nk Antagonists for Contraception
PCT:
PCT/US2021/044018 ↗
Solid Forms of Emetine
PCT:
PCT/US2021/061867 ↗
Methods of Modulation of Branched Chain Acids and Uses Thereof
Methods of Modulation of Branched Chain Acids and Uses Thereof
Methods of Managing Conditioned Fear with Neurokinin Receptor Antagonists
Methods of Modulation of Branched Chain Acids and Uses Thereof
Methods and Compositions for Treating Vasomotor Symptoms
Emetine Compounds for Treatment and Prevention of Flavivirus Infection
Methods of Managing Conditioned Fear with Neurokinin Receptor Antagonists
Emetine Compounds for Treatment and Prevention of Flavivirus Infection
Palatable Compositions Including Sodium Phenylbutyrate and Uses Thereof
Compounds and Methods for Treatment and Prevention of Flavivirus Infection
Use of Celiprolol for Treating Vascular Ehlers-Danlos Syndrome in Women During Pregnancy and Peripartum Period
Application:
16/879,511 →
Publication:
US 2021/0137859
Method of Providing Celiprolol Therapy to a Patient
Palatable Compositions Including Sodium Phenylbutyrate and Uses Thereof
Methods of Treating Urea Cycle Disorders and Maple Syrup Urine Disease
Solid Forms of Emetine
Solid Forms of Osanetant
Application:
63/218,211 →
Dosage Form for Improving Palatability of Drug Substance
Application:
63/232,011 →
Methods for Treating Patients with NK3 Antagonists Having Low Estrogen
Application:
63/305,207 →
Nk Receptor Antagonists for Treatment of Prostate Cancer
Application:
63/305,209 →
Nk Receptor Antagonists for Treatment of Prostate Cancer
Application:
63/306,215 →
Methods for Treating Patients Having Low Estrogen with NK3 Antagonists
Application:
63/306,216 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 17, 2012
From: LEE, BRENDAN
To: BAYLOR COLLEGE OF MEDICINE
Reel/Frame 027722/0807 →
Assignment of Assignor's Interest
Jun 19, 2015
From: LEE, BRENDAN
To: BAYLOR COLLEGE OF MEDICINE
Reel/Frame 035871/0394 →
Confirmatory License
Dec 30, 2016
From: EMORY UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 040808/0129 →
Assignment of Assignor's Interest
Jul 18, 2017
From: LEE, BRENDAN
To: BAYLOR COLLEGE OF MEDICINE
Reel/Frame 043036/0291 →
Assignment of Assignor's Interest
Jul 23, 2019
From: SONG, HONGJUN; MING, GUO-LI
To: THE JOHNS HOPKINS UNIVERSITY
Reel/Frame 049828/0649 →
Assignment of Assignor's Interest
Jul 23, 2019
From: TANG, HENGLI; LEE, EMILY M.; THARAPPEL, ANIL MATHEW
To: FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC.
Reel/Frame 049827/0720 →
Assignment of Assignor's Interest
Jul 23, 2019
From: ZHENG, WEI; YANG, SHU; HUANG, WENWEI; LI, HAO
To: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 049827/0647 →
Assignment of Assignor's Interest
Feb 7, 2020
From: SCHELLING, D. CHRISTOPHER
To: ACER THERAPEUTICS INC.
Reel/Frame 051852/0610 →
Assignment of Assignor's Interest
Feb 7, 2020
From: APPEL, LEAH E.; SHOCKEY, JOSHUA R.
To: GREEN RIDGE CONSULTING
Reel/Frame 051751/0736 →
Assignment of Assignor's Interest
Feb 7, 2020
From: GREEN RIDGE CONSULTING
To: ACER THERAPEUTICS INC.
Reel/Frame 051751/0791 →
Assignment of Assignor's Interest
Jun 30, 2021
From: STEINER, ROBERT A.; CHAVKIN, CHARLES; CLIFTON, DONALD K.; REED, SUSAN D.
To: UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION
Reel/Frame 056724/0842 →
Assignment of Assignor's Interest
Jul 23, 2021
From: APPEL, LEAH E.; SHOCKEY, JOSHUA R.
To: GREEN RIDGE CONSULTING
Reel/Frame 056963/0465 →
Assignment of Assignor's Interest
Jul 23, 2021
From: GREEN RIDGE CONSULTING
To: ACER THERAPEUTICS INC.
Reel/Frame 056963/0562 →
Assignment of Assignor's Interest
Jul 23, 2021
From: GREEN RIDGE CONSULTING
To: ACER THERAPEUTICS INC.
Reel/Frame 056963/0953 →
Assignment of Assignor's Interest
Jul 23, 2021
From: SCHELLING, D. CHRISTOPHER
To: ACER THERAPEUTICS INC.
Reel/Frame 056970/0959 →
Assignment of Assignor's Interest
Jul 23, 2021
From: APPEL, LEAH E.; SHOCKEY, JOSHUA R.
To: GREEN RIDGE CONSULTING
Reel/Frame 056963/0347 →
Assignment of Assignor's Interest
Jul 23, 2021
From: SCHELLING, D. CHRISTOPHER
To: ACER THERAPEUTICS INC.
Reel/Frame 057003/0552 →
Change of Name
Jun 20, 2022
From: UNIVERSITE DE PARIS
To: UNIVERSITÉ PARIS CITÉ
Reel/Frame 060390/0122 →
Merger and Change of Name
Jun 20, 2022
From: UNIVERSITE PARIS DESCARTES; UNIVERSITE PARIS DIDEROT - PARIS 7; UNIVERSITE DE PARIS
To: UNIVERSITE DE PARIS
Reel/Frame 060541/0336 →
Assignment of Assignor's Interest
Sep 13, 2022
From: FRANK, MICHAEL; JEUNEMAITRE, XAVIER; BENACHI, ALEXANDRA
To: ASSISTANCE PUBLIQUE-HÔPITAUX DE PARIS (AP-HP); UNIVERSITÉ PARIS DESCARTES
Reel/Frame 061083/0062 →
Assignment of Assignor's Interest
Oct 20, 2022
From: FRANK, MICHAEL
To: ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS (AP-HP)
Reel/Frame 061485/0230 →
Corrective Assignment to Correct the Property Number 16930208 Previously Recorded at Reel: 060390 Frame: 0122. Assignor(S) Hereby Confirms the Change of Name.
Jan 11, 2023
From: UNIVERSITE DE PARIS
To: UNIVERSITÉ PARIS CITÉ
Reel/Frame 062387/0489 →
Corrective Assignment to Correct the Property Number 16930208 Previously Recorded at Reel: 060541 Frame: 0336. Assignor(S) Hereby Confirms the Merger and Change of Name.
Jan 11, 2023
From: UNIVERSITE PARIS DESCARTES; UNIVERSITE PARIS DIDEROT - PARIS 7
To: UNIVERSITE DE PARIS
Reel/Frame 062387/0346 →
Assignment of Assignor's Interest
Feb 17, 2023
From: SCHELLING, D. CHRISTOPHER
To: ACER THERAPEUTICS INC.
Reel/Frame 062729/0328 →
Security Interest
Jul 6, 2023
From: SWK FUNDING LLC; ACER THERAPEUTICS INC
To: NANTAHALA CAPITAL MANAGEMENT, LLC
Reel/Frame 064167/0828 →